UK markets closed

Eagle Pharmaceuticals, Inc. (EGRX)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
4.1750+0.0850 (+2.08%)
As of 03:35PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Sep 2023)Next qtr. (Dec 2023)Current year (2023)Next year (2024)
No. of analysts0000
Avg. Estimate0000
Low estimate0000
High estimate0000
Year ago EPS1.121.1N/AN/A
Revenue estimateCurrent qtr. (Sep 2023)Next qtr. (Dec 2023)Current year (2023)Next year (2024)
No. of analysts1111
Avg. Estimate62.83M64.51M258.29M224.81M
Low estimate62.83M64.51M258.29M224.81M
High estimate62.83M64.51M258.29M224.81M
Year ago sales62.08M60.7M316.61M258.29M
Sales growth (year/est)1.20%6.30%-18.40%-13.00%
Earnings history29/09/202230/12/202230/03/202329/06/2023
Est. EPS0.910.831.051.05
Actual EPS1.121.11.261.18
Difference0.210.270.210.13
Surprise %23.10%32.50%20.00%12.40%
EPS trendCurrent qtr. (Sep 2023)Next qtr. (Dec 2023)Current year (2023)Next year (2024)
Current estimate0000
7 days ago1.091.074.693.48
30 days ago1.091.074.693.48
60 days ago1.091.074.693.48
90 days ago1.091.074.693.48
EPS revisionsCurrent qtr. (Sep 2023)Next qtr. (Dec 2023)Current year (2023)Next year (2024)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days1N/A11
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesEGRXIndustrySector(s)S&P 500
Current qtr.N/AN/AN/AN/A
Next qtr.N/AN/AN/AN/A
Current yearN/AN/AN/AN/A
Next yearN/AN/AN/AN/A
Next 5 years (per annum)2.70%N/AN/AN/A
Past 5 years (per annum)11.34%N/AN/AN/A